Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial

Autor:	Melisi, Davide, Zecchetto, Camilla, Merz, Valeria, Malleo, Giuseppe, Landoni, Luca, Quinzii, Alberto, Casalino, Simona, Fazzini, Federica, Gaule, Marina, Pesoni, Camilla, Casetti, Luca, Esposito, Alessandro, Marchegiani, Giovanni, Piazzola, Cristiana, D’Onofrio, Mirko, de Robertis, Riccardo, Gabbrielli, Armando, Bernardoni, Laura, Crino, Stefano F., Pietrobono, Silvia, Luchini, Claudio, Aliberti, Camillo, Martignoni, Guido, Milleri, Stefano, Butturini, Giovanni, Scarpa, Aldo, Salvia, Roberto, Bassi, Claudio
Zdroj:	In European Journal of Cancer January 2024 196
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect